SOPHARMA (SPH): Sales revenues for the first ten months of 2017 - raport 104
Raport ESPI
UNI - EN REPORT No104/2017
Sopharma AD notifies that for October 2017 the Company recorded an increase of sales revenues of 7% compared to the same month of 2016, including 3% increase of domestic sales and 12% increase of export sales.
For the first ten months of this year, revenues from sales increased by 12% compared to the same period of 2016, including 2% decrease of domestic sales and a 23% increase of export sales.
